Survival Outcomes of Ovarian Malignancies in Chinese Population

Lei Li5,000 enrolled

Overview

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary ovarian malignancies in China and relevant risk factors in a prospective cohort study.

Study Type

OBSERVATIONAL

Enrollment

5,000

Conditions

Ovarian Neoplasms Survival

Interventions

Follow up for death and recurrenceOTHER

Patients are followed up to determine the specific date of diagnosis, recurrence and death.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Primary ovarian malignancies. Exclusion Criteria: * Metastatic malignancies to ovaries.

Locations (1)

Lei Li

Beijing, China/Beiing, China

RECRUITING

Outcomes

Primary Outcomes

Overall survival

Periods from diagnosis of ovarian cancer to death

Time frame: 5 years

Progression-free survival

Periods from diagnosis of ovarian cancer or remission of disease to next recurrence

Time frame: 5 years

Central Contacts

Lei Li, MD

CONTACT

13911988831 lileigh@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.